Takeda Uses Fine Tooth Comb To Find Inefficiencies After Poor Results
This article was originally published in PharmAsia News
Executive Summary
The belt-tightening has already hit Takeda’s oncology arm, leading to the exit of Deborah Dunsire, chief executive officer at Millennium: The Takeda Oncology Co.
You may also be interested in...
FCPA In The China Framework Warrants Special Attention
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.
Astellas Regains Japan Losses With Xtandi Expansion
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.